Work

ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis

Year: 2022

Type: article

Source: Nature

DOI: 10.1038/s41586-022-04753-7

Authors: Ting Zhang, Chaoran Yin, Aleksandr Fedorov, Liangjun Qiao, Hongliang Bao, Nazar Beknazarov, Shiyu Wang, Avishekh Gautam, Riley M. Williams, Jeremy Chase Crawford, Suraj Peri, Vasily Studitsky, Amer A. Beg, Paul G. Thomas, Carl Walkley, Yan Xu, Maria Poptsova, Alan Herbert, Siddharth Balachandran

Institutions: Fox Chase Cancer Center, National Research University Higher School of Economics, Chongqing Medical University, University of Miyazaki, St. Jude Children's Research Hospital, Lomonosov Moscow State University, Moffitt Cancer Center, The University of Melbourne, St Vincent's Hospital Melbourne, St Vincents Institute of Medical Research, InsideOutBio (United States)

Language: English

Topic: RNA regulation and disease

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Japan Society for the Promotion of Science, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer, G1256809519, G156276794, G2761060103, G4913949648, Elucidating Higher-Order DNA and RNA Structures in Cells via 19F NMR Molecular Technology, G8906026615, Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death, G997507850

OpenAlex ID: W4281486773

FWCI: 22.68

Cites: 69

Cited by: 413

Related to: 10